Global Platform Trial Aims to Transform Treatment of Children With Relapsed B-Cell Lymphoma
An international adaptive platform trial called Glo-BNHL will simultaneously test bispecific antibodies, antibody-drug conjugates and CAR T-cells in children and ...
